Patent · US Active

Compositions and methods for treating neoplasia, inflammatory disease and other disorders

US9320741B2 · kind B2 · utility

21Cited by
15References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 30, 2014
Grant dateApr 26, 2016
Priority date
Expiry dateSep 30, 2034

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention features compositions and methods for treating or preventing a neoplasia. More specifically, the invention provides compositions and methods for disrupting the interaction of a BET family polypeptide comprising a bromodomain with chromatin (e.g., disrupting a bromodomain interaction with an acetyl-lysine modification present on a histone N-terminal tail).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.